IRIS

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

Montecucco C;
2011-01-01
2011
ANNALS OF THE RHEUMATIC DISEASES
2-s2.0-79955806071
Esperti anonimi
Inglese
Internazionale
STAMPA
70
6
909
920
12
21378402
Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Rheumatology; Immunology and Allergy; Immunology; Biochemistry, Genetics and Molecular Biology (all)
http://ard.bmj.com/content/70/6/909.full.pdf
33
info:eu-repo/semantics/article
262
Buch, Maya H.; Smolen, Josef S.; Betteridge, Neil; Breedveld, Ferdinand C.; Burmester, Gerd; Dörner, Thomas; Ferraccioli, Gianfranco; Gottenberg, Jacq...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1223702
Citazioni
  • ???jsp.display-item.citation.pmc??? 160
  • Scopus 411
  • ???jsp.display-item.citation.isi??? ND
social impact